| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/20/2008 | EP1957037A1 Novel pharmaceutical composition consisting of water-soluble or poorly water-soluble active substances |
| 08/20/2008 | EP1956910A2 Oncogenic ras-specific cytotoxic compound and methods of use thereof |
| 08/20/2008 | EP1956908A2 Certain compositions and methods of treatment |
| 08/20/2008 | EP1956906A2 Methods, compositions, and kits for the treatment of medical conditions |
| 08/20/2008 | EP1956904A2 Use of low-dose ladostigil for neuroprotection |
| 08/20/2008 | EP1956894A2 Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent |
| 08/20/2008 | EP1896077A4 Methods and compositions for the prevention and treatement of inflammatory disease |
| 08/20/2008 | EP1838309B1 Chromane derivatives useful as acid pump antagonists |
| 08/20/2008 | EP1836215B1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions |
| 08/20/2008 | EP1778632B1 Indoles useful in the treatment of inflammation |
| 08/20/2008 | EP1778624B1 Tyrosine derivatives as ppar-gamma-modulators |
| 08/20/2008 | EP1768661B1 Use of targeted oxidative therapeutic formulation in treatment of burns |
| 08/20/2008 | EP1756066B1 Tetrasubstituted imidazole derivatives as cannabinoid cb1 receptor modulators with a high cb1/cb2 receptor subtype selectivity |
| 08/20/2008 | EP1750716B1 Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin |
| 08/20/2008 | EP1745052B1 Hiv integrase inhibitors: cyclic pyrimidinone compounds |
| 08/20/2008 | EP1742947B1 6-substituted pyridoindolone derivatives production and therapeutic use thereof |
| 08/20/2008 | EP1737438B1 Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome |
| 08/20/2008 | EP1732547B1 Anti-hiv quinuclidine compounds |
| 08/20/2008 | EP1692129B1 Keto lactam compounds and use thereof |
| 08/20/2008 | EP1691802A4 Methods for the amelioration of environmental oxidant stress and the regulation of beneficial genes |
| 08/20/2008 | EP1685102A4 Melanocortin receptor agonists |
| 08/20/2008 | EP1678130B1 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds |
| 08/20/2008 | EP1670790B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 08/20/2008 | EP1670770B1 Benzimidazole derivatives, compositions containing them, preparation therof and uses thereof |
| 08/20/2008 | EP1667947B1 Methods of 11c -radiolabelling phenothiazine and pheno thiazine-like compounds |
| 08/20/2008 | EP1666880B1 Screening method |
| 08/20/2008 | EP1660492B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 08/20/2008 | EP1648517B1 Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
| 08/20/2008 | EP1628945B1 Depigmenting agents |
| 08/20/2008 | EP1622602B1 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 08/20/2008 | EP1616873B1 Lipid-regulating agent and use thereof |
| 08/20/2008 | EP1613354B1 Use of cyclic acetals/ cetals for improved penetration of active substances into cells and organs |
| 08/20/2008 | EP1603927B1 Optically detectable (alkylacyl-2-aminodesoxy-glycero)-nitrophenyl-phosphonates |
| 08/20/2008 | EP1587821B1 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 08/20/2008 | EP1569935B1 Heterocyclic compounds, preparation method thereof and use of same as medicaments, such as anti-bacterial medicaments and beta-lactamase inhibitors |
| 08/20/2008 | EP1569647B1 Cyclohexyl compounds as ccr5 antagonists |
| 08/20/2008 | EP1567523B1 Indolyl derivatives |
| 08/20/2008 | EP1545537B9 Alpha-7 nicotinic receptor agonists and statins in combination |
| 08/20/2008 | EP1542663B1 A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 08/20/2008 | EP1539731B9 Novel compounds |
| 08/20/2008 | EP1509618B1 Autoimmune conditions and nadph oxidase defects |
| 08/20/2008 | EP1509521B1 1h-imidazo[4,5-c]quinoline derivatives for the treatment of protein kinase dependent diseases |
| 08/20/2008 | EP1509223B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/20/2008 | EP1509205B1 Pharmaceutical composition having a delayed active substance release and method for the preparation thereof |
| 08/20/2008 | EP1482976B1 A preparation and method for weight reduction |
| 08/20/2008 | EP1482935B1 Thiazole and oxazole derivatives which modulate ppar activity |
| 08/20/2008 | EP1459765B1 6-fluorobicyclo 3.1.0 hexane derivatives |
| 08/20/2008 | EP1456203B1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 08/20/2008 | EP1453812B1 Cytotoxic agents |
| 08/20/2008 | EP1451202B1 Aryl fused azapolycyclic compounds |
| 08/20/2008 | EP1424071B1 Perfume compositions |
| 08/20/2008 | EP1404653B1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 08/20/2008 | EP1387681B1 Use of castanospermine derivatives for the treatment of hepatitis c |
| 08/20/2008 | EP1380302B1 Remedies for retina and choroid diseases containing steroids as the active ingredient |
| 08/20/2008 | EP1375489B1 Medicinal composition containing 1,3-thiazine derivative |
| 08/20/2008 | EP1368049B1 Inhibition of atf2 activity to treat cancer |
| 08/20/2008 | EP1363639B1 PYRROLO 2,3-d PYRIMIDINE AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 08/20/2008 | EP1356052B1 Production of full antibodies in procaryotic cells |
| 08/20/2008 | EP1349552B1 PYRAZOLO[3,4-d]PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 08/20/2008 | EP1337251B1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 08/20/2008 | EP1331902B1 Improved ophthalmic and contact lens solutions containing forms of vitamin b |
| 08/20/2008 | EP1318993B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 08/20/2008 | EP1289993B9 Caspase inhibitors and uses thereof |
| 08/20/2008 | EP1282429B1 Pharmaceutical gel composition |
| 08/20/2008 | EP1255547B1 Controlled-release compositions containing opioid agonist and antagonist |
| 08/20/2008 | EP1249233B1 Npyy5 antagonists |
| 08/20/2008 | EP1228210B1 A method for detecting prostate cancer |
| 08/20/2008 | EP1221867B2 Nutritional composition comprising an anandamide precursor |
| 08/20/2008 | EP1221445B1 Pentacyclic taxane compounds |
| 08/20/2008 | EP1210947B1 Ophthalmic ointment comprising vancomycin hydrochloride for treating infective eye diseases |
| 08/20/2008 | EP1198589B1 Tenascin-c nucleic acid ligands |
| 08/20/2008 | EP1176969B1 Substitution infusion fluid and citrate anticoagulation |
| 08/20/2008 | EP1140209B1 Blood pool agents for nuclear magnetic resonance diagnostics |
| 08/20/2008 | EP1105111B1 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 08/20/2008 | EP1087992B1 Antithrombotic compounds |
| 08/20/2008 | EP1075493B1 Dna encoding snorf25 receptor |
| 08/20/2008 | EP1044017B1 Supplement for dialysis patients |
| 08/20/2008 | EP1033985B2 Stable ascorbic acid preparation for topical use |
| 08/20/2008 | EP0939829B1 Methods of modulating melanin synthesis |
| 08/20/2008 | EP0883404B1 Combination therapy for osteoporosis |
| 08/20/2008 | EP0826042B1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 08/20/2008 | EP0705111B1 Agent with influences hyperactive immunological effector cells |
| 08/20/2008 | EP0703897B1 Lipoxin compounds with prolonged half-life |
| 08/20/2008 | CN201101805Y Waistline for lumbar vertebra health therapy |
| 08/20/2008 | CN101248353A Methods and compositions for the treatment of lipid-associated disorders |
| 08/20/2008 | CN101248105A Polymer conjugates of K-252a and derivatives thereof |
| 08/20/2008 | CN101248080A Inhibitors of VEGF receptor and HGF receptor signaling |
| 08/20/2008 | CN101248079A Antiarrhythmic precursor compounds, methods of synthesis and methods of use |
| 08/20/2008 | CN101248078A Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 08/20/2008 | CN101248077A P38 MAP kinase inhibitors and methods for using the same |
| 08/20/2008 | CN101248076A Acetylenic piperazines as metabotropic glutamate receptor antagonists |
| 08/20/2008 | CN101248074A Xanthine oxidase inhibitor |
| 08/20/2008 | CN101248073A Heteroaryl-substituted diazatricycloalkanes and methods of use thereof |
| 08/20/2008 | CN101248072A 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| 08/20/2008 | CN101248071A Bicyclic piperazines as metabotropic glutamate receptor antagonists |
| 08/20/2008 | CN101248070A 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 08/20/2008 | CN101248069A Androgen receptor modulators and method of treating disease using the same |
| 08/20/2008 | CN101248067A Oxazolidinone derivatives and use thereof as antibiotics |
| 08/20/2008 | CN101248066A Non-steroidal progesterone receptor modulators |
| 08/20/2008 | CN101248065A Activator of peroxisome proliferator activated receptor delta |